Stay updated on Safe Doses CX-188 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.

Latest updates to the Safe Doses CX-188 in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor UI update; no observable changes to study details or data.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a minor site version update in the footer, from v3.4.0 to v3.4.1, with no impact on study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary display option and a site revision notice (Revision: v3.4.0). Labeling updates include capitalization tweaks and wording changes (No FEAR Act Data; Last Update Submitted that Met QC Criteria), to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to trial details or core content were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section added with Virginia as a listed site. HHS Vulnerability Disclosure and Virginia Locations references were removed; revision updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedFooter Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Safe Doses CX-188 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.